

Startup · United Kingdom
LightOx
HQ Newcastle upon Tyne, United KingdomFounded 201611-50 employeesUpdated
Illuminating therapeutics & research tools.
Funding3 rounds · ~$2.0M
- Equity raised
- ~$2.0M
- Debt, secondaries & grants
- ~$1.3M
- Latest
- ~$1.9MStage undisclosed · May 3, 2024
| Announced | Stage | Amount | Valuation | Lead investors | Other investors | Confidence |
|---|---|---|---|---|---|---|
| May 3, 2024 | Undisclosed | ~$1.9M | — | — | — | Reported |
| Jan 30, 2023 | Grant | ~$1.3M | — | — | — | Reported |
| 2026 | Pre-Seed | $117K | — | — | — | Reported |
- Undisclosed~$1.9MMay 3, 2024
- Grant~$1.3MJan 30, 2023
- Pre-Seed$117K2026
Raised counts equity rounds; debt, secondary sales and grants are totaled separately. Amounts in other currencies are converted at the announcement month's average rate. A ~ marks an estimated or converted amount.
Systems2
Newest unveiled first. Systems that belong to a government program link to the program page, where variants, costs and contracts are.
People4
| Person | Role |
|---|---|
| Andy Whiting · LinkedIn ↗ | Co-Founder and CTO |
| Carrie Ambler · LinkedIn ↗ | Co-Founder and CSO |
| Carrie Ambler · LinkedIn ↗ | Co-Founder and CSO |
| Sam Whitehouse | CEO |
Sources8
Profile3
- 1CompanyHOME - LIGHTOX
LightOx · Supports Organization · description, Organization · hq city, Organization · name, Organization · website
“Illuminating therapeutics & research tools. LightOx are developing new therapeutic solutions to improve patient’s function and long-term outcomes with oral cancer. We have a unique range of molecular tools for use in imaging, therapeutics and assay development.”
- 2
PitchBook · Supports Organization · employee range, Organization · founded year, Organization · linkedin url, Organization · x url
“employee_range: 11-50 (profile: 17)”
- 3
Sixth-Domain · Supports Organization · country, Organization · kind
“{"country": "UK", "hq_iso2": "GB", "id": "b7907091-87de-4d06-b622-baeeb72e3574"}”
Systems2
- 4CompanyLXD191 - LIGHTOX
LightOx · Supports System
“LightOx lead candidate LXD191 is formulated to be applied topically to pre-cancerous lesions in the oral cavity.”
- 5CompanyWound Care - LIGHTOX
LightOx · Supports System
“###### THERAPEUTICS I LXD231 # We are developing a wound care treatment.”
Funding2
- 6
Crunchbase · Jan 1, 2026 · Supports Funding round · amount, Organization · ownership
“Pre Seed Round - Lightox”
- 7DatabaseLightOx Ltd company profile
Octen Business Search · Supports Funding round, Organization · hq region, Role
“funding round: Venture Round, 2024-05-03, GBP 1,500,000”
People1
- 8
Crunchbase · Supports Organization · employee range, Organization · hq city, Organization · linkedin url, Role
“employee_range: 11-50 (profile: 11-50)”
Each fact on this page is attached to the sources that support it. Archived copies are linked when we keep one.
